SCHEMBL625119

SCHEMBL625119

O=C1CCCC1=Cc1ccc(Br)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.68
AKR1C1 Q04828 1/20 0.68
HTT P42858 3/20 0.67
ALDH1A1 P00352 1/20 0.67
MAPT P10636 3/20 0.57
HPGD P15428 2/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
EGFR P00533 2/20 0.55
XDH P47989 1/20 0.55
CYP1A2 P05177 5/20 0.50
HSD11B1 P28845 2/20 0.50
F3 P13726 2/20 0.50
CYP2C9 P11712 1/20 0.50
EP300 Q09472 1/20 0.46
KMT2A Q03164 1/20 0.46
HSP90AA1 P07900 1/20 0.46
XBP1 P17861 1/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL809546 1.00 AKR1C3 (0.68) AKR1C3AKR1C1HTTALDH1A1MAPT
SCHEMBL1524863 1.00 AKR1C3 (0.68) AKR1C3AKR1C1HTTALDH1A1MAPT
SCHEMBL624537 0.96 AKR1C3 (0.62) AKR1C3AKR1C1HTTALDH1A1MAPT
SCHEMBL21612525 0.96 AKR1C3 (0.62) AKR1C3AKR1C1HTTALDH1A1MAPT
SCHEMBL3438398 0.96 AKR1C3 (0.62) AKR1C3AKR1C1HTTALDH1A1MAPT
SCHEMBL17899490 0.86 EGFR (0.69) HTTMAPTHPGDNPC1RAB9A
SCHEMBL30969583 0.86 EGFR (0.69) HTTMAPTHPGDNPC1RAB9A
SCHEMBL11218559 0.82 AKR1C3 (0.70) AKR1C3AKR1C1HTTALDH1A1MAPT
SCHEMBL11218557 0.82 AKR1C3 (0.70) AKR1C3AKR1C1HTTALDH1A1MAPT
SCHEMBL643539 0.81 HSD11B1 (0.76) AKR1C3AKR1C1HTTALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415505-B2 2-methylene-5-substituted-methylenecyclopentanone derivatives and use thereof SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2013-04-09 US disclosed
WO-2012021692-A1 CURCUMIN ANALOGS AND METHODS OF USE THEREOF RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2012-02-16 WO disclosed
US-7968734-B2 Organocatalysts and methods of use in chemical synthesis STC.UNM (US) 2011-06-28 US disclosed
US-20110060054-A1 2-METHYLENE-5-SUBSTITUTED-METHYLENECYCLOPENTANONE DERIVATIVES AND USE THEREOF SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2011-03-10 US disclosed
EP-2248796-A1 2-METHYLENE-5-SUBSTITUTED METHYLENE CYCLOPENTANONE DERIVATIVES AND USE THEREOF Shenyand Pharmaceutical University (CN) 2010-11-10 EP disclosed
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis STC.UNM (US) 2007-10-18 US disclosed
US-5639918-A Intermediate compounds useful in the preparation of fungicidal compositions containing (benzylidene)-azolylmethyclycloalkane RHONE-POULENC AGROCHIMIE (FR) 1997-06-17 US disclosed
CN-1031971-C (Benzylidene)-azolylmethylcycloalkane and use as fungicide RHONE POULENC AGROCHIMIE (FR) 1996-06-12 CN disclosed
EP-0378953-B1 Benzylidene azolyl methyl cycloalkane and its use as a fungicide RHONE POULENC AGROCHIMIE (FR) 1996-06-05 EP disclosed
US-5380743-A Fungicidal compositions containing (benzylidene)-azolymethylcycloalkane RHONE-POULENC AGROCHIMIE (FR) 1995-01-10 US disclosed
US-5256683-A Plant protective agent 1H-1,2,4-triazolylmethylcycloalkane or -alkene benzylidene RHONE-POULENC AGROCHIMIE (FR) 1993-10-26 US disclosed
EP-0378953-A1 Benzylidene azolyl methyl cycloalkane and its use as a fungicide RHONE-POULENC AGROCHIMIE (FR) 1990-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis SCO2, CBR1, CBR3 AKR1C3 4/4885AKR1C1 10/4885HTT 2422/4885
US-20110060054-A1 2-METHYLENE-5-SUBSTITUTED-METHYLENECYCLOPENTANONE DERIVATIVES AND USE THEREOF BRCA1, KLK3, DPYD AKR1C3 435/4885AKR1C1 470/4885HTT 4441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.